Position in BMY
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$3,447,692
-$176,698 QoQ
Shares Held
59,835
-11.0% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#653
of 2,506 holders
Holding Since
Jun 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026J.W. COLE ADVISORS, INC. holds $121,333,460 across 13 Drug Manufacturers - General names. BMY ranks #8 (2.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
30,412 | $36,477,068 | |
| 2 | JNJ |
Johnson & Johnson
|
113,666 | $28,867,754 | |
| 3 | ABBV |
AbbVie Inc.
|
73,916 | $18,600,222 | |
| 4 | MRK |
Merck & Co., Inc.
|
100,135 | $12,867,347 | |
| 5 | AMGN |
Amgen Inc
|
16,509 | $5,978,239 | |
| 6 | PFE |
Pfizer Inc
|
235,737 | $5,676,546 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
30,495 | $3,852,738 | |
| 8 | BMY |
Bristol Myers Squibb Co
This page
|
59,835 | $3,447,692 |
All Filings in BMY
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,447,692 | 59,835 | Shares | Sole | 2026-07-21 | |
| 2025-12-31 | $3,624,390 | 67,193 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $3,171,792 | 70,328 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $3,260,250 | 70,431 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $3,772,292 | 61,851 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $1,138,043 | 20,121 | Shares | Sole | 2025-01-31 | |
| 2024-09-30 | $1,027,659 | 19,862 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $997,010 | 24,007 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $1,661,010 | 30,629 | Shares | Sole | 2024-04-30 | |
| 2023-12-31 | $1,633,248 | 31,831 | Shares | Sole | 2024-01-31 | |
| 2023-09-30 | $1,686,526 | 29,058 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $1,700,430 | 26,590 | Shares | Sole | 2023-07-27 | |
| 2023-03-31 | $1,989,959 | 28,711 | Shares | Sole | 2023-05-03 | |
| 2022-12-31 | $2,016,398 | 28,025 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,929,666 | 27,144 | Shares | Sole | 2022-10-31 | |
| 2022-06-30 | $2,096,556 | 27,228 | Shares | Sole | 2022-07-27 | |
| 2021-12-31 | $1,921,377 | 30,816 | Shares | Sole | 2022-01-25 | |
| 2021-09-30 | $1,857,405 | 31,391 | Shares | Sole | 2021-10-26 | |
| 2021-06-30 | $1,799,262 | 26,927 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $1,971,865 | 31,235 | Shares | Sole | 2021-04-28 | |
| 2020-12-31 | $2,012,687 | 32,447 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $5,336,991 | 88,522 | Shares | Sole | 2020-11-05 | |
| 2020-06-30 | $1,593,538 | 27,101 | Shares | Sole | 2020-08-07 | |
| No filing history on record for this holder in this stock. | ||||||